Option strategists at Goldman Sachs recommended buying April Bristol-Myers Squibb Company (NYSE: BMY) calls to capture Ipilimumab ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE